Neuropsychiatric manifestations of viral infections (both per se and secondary to the
neuroinflammatory reaction of the host) are mainly attributed to immunological reactions, so …

As of 26 July 2023, the SARS-CoV-2 virus has caused 768,560,727 confirmed cases of the
Coronavirus disease 2019 (COVID-19), and 6,952,522 fatalities worldwide [1]. Although the …

Neuropsychiatric manifestations of viral infections (both per se and secondary to the
neuroinflammatory reaction of the host) are mainly attributed to immunological reactions, so …

Background COVID‐19 convalescent plasma (CCP) was approved under emergency
authorization to treat critically ill patients with COVID‐19 in the United States in 2020. We …

Background: To explore the association between the self-reported health status, depressive
tendency, psychological capital, and self-acceptance of college students in China during the …

SARS-CoV-2 has the ability to form large multi-nucleated cells known as syncytia. Little is
known about how syncytia affect the dynamics of the infection or severity of the disease. In …

COVID-19 has significantly affected public health, social life, and economies worldwide. The
only effective way to combat the pandemic is through vaccines. Although the vaccines have …

Background: Respiratory infections are one of the most common comorbidities identified in
hospitalized patients. The coronavirus disease 2019 (COVID-19) pandemic greatly impacted …

Background: Altough Coronavirus Disease 2019 (COVID-19) disease mainly affects the
pulmonary system, studies on male reproductive health are limited. We aimed to investigate …

The biologically and medically important heparan sulphate and heparin polysaccharides
have been previously shown to mediate viral cell entry for enveloped viruses. Furthermore …